Analysis of protective effects of a new UV device system for peritonitis in PD patients.
Not Applicable
Recruiting
- Conditions
- End-Stage Renal Disease (ESRD)
- Registration Number
- JPRN-UMIN000013942
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 230
Inclusion Criteria
Not provided
Exclusion Criteria
Should be excluded even if one of them would be positive; patients under 20 years old, patients continuing PD therapy more than 3 years, or patients on PD therapy except for Baxter system.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Duration until the first incidence of peritonitis 2. Incidence of total peritonitis 3. Incidence of peritonitis related to touch-contamination during bag exchanges
- Secondary Outcome Measures
Name Time Method 1. Peritoneal function (D/P Cre) 2. Residual renal function (residual Kt/V, residual CCre) 3. Technical failure (Duration of PD therapy until withdrawal from PD therapy, prognosis)